"La Fondazione Istituto Neurologico Casimiro Mondino di Pavia. La fondazione Istituto Neurologico Casimiro Mondino è configurata giuridicamente come Istituto di Ricovero e Cura a Carattere Scientifico di diritto privato. La Fondazione Istituto Neurologico Casimiro Mondino è specializzata nella diagnosi e cura del sistema nervoso. La Fondazione Istituto Neurologico Casimiro Mondino di Pavia cura le seguenti patologie: cefalee, epilessie, disturbi del sonno, disfagie neurogene, malattie cerebrovascolari, neuromuscolari, di Parkinson, sclerosi multipla e neuropsichiatria infantile. La Fondazione Istituto Neurologico Casimiro Mondino dedica particolare attenzione al proprio personale sia medico sia tecnico ed infermieristico."

During the past decade, IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla" are "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials), "Progressive Multiple Sclerosis (PMS)" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla" in a lesser frequency.

Most popular intervention types in "IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (5 trials), "Antihistamine" (1 trials), "Fenebrutinib" (1 trials), "Methylprednisolone" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla" are 6 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Istituto Neurologico C. Mondino-Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".